Your browser doesn't support javascript.
loading
Peripheral Blood Markers Predictive of Progression-Free Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Treated With PD-1 Inhibitors Plus Chemotherapy as First-Line Therapy.
Chen, Wei; Li, Dapeng; Bian, Xuyu; Wu, Yan; Xu, Mengdan; Wu, Mengyao; Tao, Min.
Affiliation
  • Chen W; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Li D; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Bian X; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Wu Y; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Xu M; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Wu M; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Tao M; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Nutr Cancer ; 75(1): 207-218, 2023.
Article in En | MEDLINE | ID: mdl-36190755
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nutr Cancer Year: 2023 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Esophageal Squamous Cell Carcinoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nutr Cancer Year: 2023 Document type: Article Affiliation country: China Country of publication: United States